Personal information

Countries

Italy, Germany, Netherlands, France

Activities

Collapse all

Employment (6)

Eindhoven University of Technology: Eindhoven, Noord-Brabant, NL

2019-09-01 to 2021-03-10 | Researcher - PhD candidate
Employment
Source: Self-asserted source
Dario Valenti

Taros Chemicals GmbH und Co KG: Dortmund, Nordrhein-Westfalen, DE

2016-08-15 to 2020-02-01 | Research Chemist
Employment
Source: Self-asserted source
Dario Valenti

Università degli Studi di Siena: Siena, Toscana, IT

2019-04-01 to 2019-05-15 | Researcher - visiting
Employment
Source: Self-asserted source
Dario Valenti

CNRS: Lille, FR

2018-01-01 to 2018-04-20 | Researcher - visiting
Employment
Source: Self-asserted source
Dario Valenti

Università degli Studi di Pavia: Pavia, Lombardia, IT

2016-04-01 to 2016-07-31 | Researcher - undergraduate (Scienze del Farmaco)
Employment
Source: Self-asserted source
Dario Valenti

University of Vienna: Vienna, AT

2015-10-01 to 2016-03-07 | Researcher - Intern
Employment
Source: Self-asserted source
Dario Valenti

Education and qualifications (3)

Eindhoven University of Technology: Eindhoven, Noord-Brabant, NL

2019-09-01 to 2021-03-10 | PhD in Medicinal Chemistry
Qualification
Source: Self-asserted source
Dario Valenti

Università degli Studi di Pavia: Pavia, Lombardia, IT

2015-02 to 2016-04 | II level Master degree in Drug Design and Development
Education
Source: Self-asserted source
Dario Valenti

Università di Bologna: Bologna, Italy, IT

2010-10-01 to 2014-03-05 | MSc in Chemistry and Pharmaceutical Technologies
Education
Source: Self-asserted source
Dario Valenti

Funding (1)

H2020-MSCA-ITN-2015

Grant
European Commission (., BE)
Part of GRANT_NUMBER:

675179
Source: Self-asserted source
Dario Valenti

Works (6)

An Exploration of Chemical Properties Required for Cooperative Stabilization of the 14-3-3 Interaction with NF-κB—Utilizing a Reversible Covalent Tethering Approach

Journal of Medicinal Chemistry
2021-06-02 | Journal article
DOI: 10.1021/acs.jmedchem.1c00401
Source: Self-asserted source
Dario Valenti

Reversible Covalent Imine-Tethering for Selective Stabilization of 14-3-3 Hub Protein Interactions

Journal of American Chemical Society
2021-05-28 | Journal article
DOI: 10.1021/jacs.1c03035
Source: Self-asserted source
Dario Valenti

Multifaceted activity of polyciclic MDR revertant agents in drug-resistant leukemic cells: Role of the spacer

Bioorganic Chemistry
2021-01-01 | Journal article
DOI: 10.1016/j.bioorg.2020.104460
Source: Self-asserted source
Dario Valenti

Fragment-Based Stabilizers of Protein-Protein Interactions through Imine-Based Tethering

Angewandte Chemie International Edition
2020-08-20 | Journal article
DOI: 10.1002/anie.202008585
Source: Self-asserted source
Dario Valenti

Set-up and screening of a fragment library targeting the 14-3-3 protein interface

MedChemComm
2019 | Journal article
DOI: 10.1039/C9MD00215D
Source: Self-asserted source
Dario Valenti
grade
Preferred source (of 2)‎

Clinical candidates modulating protein-protein interactions: The fragment-based experience

European Journal of Medicinal Chemistry
2019-04-01 | Journal article
DOI: 10.1016/j.ejmech.2019.01.084
Source: Self-asserted source
Dario Valenti
How many people are using ORCID?